Skip to content

Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke

Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05921682
Enrollment
100
Registered
2023-06-27
Start date
2023-05-28
Completion date
2026-03-31
Last updated
2024-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heat Stroke

Keywords

heat stroke, body temperature, outcomes

Brief summary

The goal of this observational study is to explore the optimal target body temperature in first 24 hours and the relationship between body temperature and adverse outcomes of heat stroke. The main questions it aims to answer are: * the optimal target body temperature at 0.5 h, 2 h, and the lowest body temperature of heat stroke. * the best body temperature at the cutting point of stop cooling. * The relationship between the volume and speed of ice saline infusion and the cooling effect.

Interventions

OTHERobservation

This study is an observational study. Patients will receive conventional cooling measures and organ function support.

Sponsors

Yiwu Central Hospital
CollaboratorOTHER
Jinhua People's Hospital
CollaboratorOTHER
Jinhua Municipal Central Hospital
CollaboratorOTHER
Dongyang People's Hospital
CollaboratorOTHER
Lanxi People's Hospital
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* ≥ 18 years; ② diagnosed as heat stroke; ③ Informed consent from patients or family members.

Exclusion criteria

* need immediate cardiopulmonary resuscitation; ② transferred from another hospital; ③ with severe underlying organ insufficiency; ④ pregnant women.

Design outcomes

Primary

MeasureTime frameDescription
mortalityup to 90 daysNumber of participants who dead during hospitalization
organ damageup to 90 daysNumber of participants with organ damage, including but not limited to brain, lung, heart, kidney, liver and coagulation

Secondary

MeasureTime frameDescription
continuous renal replacement therapyup to 90 daysNumber of participants who need CRRT
length of ICU stayup to 90 daysThe length patient stay in ICU
length of hospital stayup to 90 daysThe length patient stay in hospital

Countries

China

Contacts

Primary ContactXiuqin Feng
fengxiuqin@zju.edu.cn+8613757119151
Backup ContactLan Chen
jhchenlan2003@hotmail.com+8613819987120

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026